Abstract: A cooling system for a power connector of a charging inlet assembly includes a cooling adapter coupled to a housing of the charging inlet assembly including an adapter body forming a cavity. The cooling adapter includes supply and return ports adjacent a cable exit. The cooling system includes a heat exchanger positioned in the cavity of the cooling adapter including a heat exchanger body configured to receive the power cable and/or the terminal. The heat exchanger body is thermally coupled to the power cable or the terminal to dissipate heat therefrom.

Abstract: A charging inlet assembly for an electric vehicle includes a housing having a power connector including AC terminals and DC terminals. An AC terminal assembly is coupled to the housing and includes AC bus bars electrically connected to corresponding AC terminals at a separable mating interface. A DC connector is mechanically and electrically connect to the DC contact of the DC connector at a separable mating interface.

Abstract: The disclosure relates to a III-nitride power semiconductor based heterojunction device including a low voltage terminal, a high voltage terminal, a control terminal and an active heterojunction transistor formed on a substrate, and further including the following monolithically integrated components: voltage clamp circuit configured to limit a maximum potential that can be applied to the internal gate terminal, an on-state circuit configured to control the internal gate terminal of the active heterojunction transistor during an on-state operation, a turn-off circuit configured to control the internal gate terminal of the active heterojunction transistor during a turn-off operation and during an off-state.

Abstract: The present invention relates to fusion proteins comprising an insulin receptor agonist fused to a human IgG Fc region through the use of a peptide linker, and the use of such fusion proteins in the treatment of diabetes. The fusion protein of the present invention has an extended time action profile and is useful for providing basal glucose control for an extended period of time.

Abstract: An electronic component includes a circuit carrier unit and a housing at least partly encompassing the circuit carrier unit. The circuit carrier unit has an electronic element assembled on the circuit carrier unit. The circuit carrier unit has a first section and a second section arranged at a distance from the first section and opposing the first section. The housing has a first receiving portion receiving the first section and a second receiving portion receiving the second section. The first receiving portion and the second receiving portion are separated from each other by a cooling clearance.

Abstract: A device adapted to be secured to the foot of a user includes one or more vibration actuators configured to provide vibrations to the user's foot, one or more force or acceleration sensors configured to sense forces or acceleration exerted by the user's foot, and a controller configured to operate the vibration actuators in a continuous mode to provide intermittent vibration to the user's foot independent of information sensed by the force or acceleration sensors. The vibration includes a first period of continuous vibration followed by a second period of no vibration followed by a third period of continuous vibration. The device may also be configured to operate in a feedback mode.

Abstract: A thermal sensing system includes an electrical contact, a sensing element, and at least one position sensor. The electrical contact releasably connects to a mating contact for establishing a conductive path across a mating interface. The electrical contact defines a channel therein that extends from an opening along an outer surface of the electrical contact. The sensing element is at least partially outside of the channel and is configured to move relative to the electrical contact from a first position to a second position based on a temperature increase within the channel that exceeds a designated threshold temperature. The at least one position sensor is spaced apart from the electrical contact and is configured to detect a position change of the sensing element from the first position to the second position, indicating that the temperature within the channel exceeds the designated threshold temperature.

Abstract: An adhesive and release liner application system and method. A bottom table is slidable with respect to a frame and a middle table is slidable with respect to the bottom table. An elevator drive subsystem between a top table and the middle table is configured to adjust the elevation of the top table relative to the middle table. An adhesive head, connected to an adhesive supply subsystem, a release liner applicator, a release liner cutter, and a staple gun are mounted to the top table for applying the adhesive to a surface of a structural member positioned adjacent the top table, for applying a release liner over the adhesive on the surface, for inserting at least one staple through the release liner and into the surface, and for cutting the release liner.

Abstract: An improved solvent system for the formulation and application of N-alkyl thiophosphoric triamide urease inhibitors. These formulations provide safety and performance benefits relative to existing alternatives and enable storage, transport and subsequent coating or blending with urea based or organic based fertilizers. These formulations are comprised primarily of environmentally friendly aprotic and protic solvents (particularly dimethyl sulfoxide and alcohols/polyols) to stabilize the urease inhibitor.

Abstract: An improved solvent system for the formulation and application of N-alkyl thiophosphoric triamide urease inhibitors. These formulations provide safety and performance benefits relative to existing alternatives and enable storage, transport and subsequent coating or blending with urea based or organic based fertilizers. These formulations are comprised primarily of environmentally friendly aprotic and protic solvents (particularly dimethyl sulfoxide and alcohols/polyols) to stabilize the urease inhibitor.

Abstract: An alignment mechanism for a robotic parking device is described. The device includes a number of stacks of containers, the stacks being positioned within a frame structure having uprights and a horizontal grid disposed above the stacks, the grid having substantially perpendicular rails on which load handling devices can run. Cars or vehicles are positioned in containers that are moved in to and out of the stacks by the robotic handling devices. The cars are put in to the grid at entry points that can be positioned at points under the stacks. The alignment mechanism includes a series of belts moveable relative to each other and relative to the container, the belts acting to align a long axis of a vehicle with a long axis of the container in to which the vehicle is to be placed.

Abstract: A radio frequency (RF) communication system may include mobile vehicles, with each mobile vehicle including RF equipment and a controller. The controller may be configured to determine a reward matrix based upon possible RF equipment configurations and associated operational parameters, and operate the RF equipment to implement an RF equipment configuration based upon the reward matrix. The system may also include an oversight controller configured to update respective reward matrices of the mobile vehicles.

Abstract: Methods, software products, digital cameras and other image processing systems process a set of transform coefficients. In at least one embodiment, the method comprises, for each block of transform coefficients representing an image: ordering the block's coefficients into a sequence; encoding the ordered coefficients to yield a sequence of codewords, each codeword including one or more encoded coefficients; and dividing the sequence of codewords into two or more sub-sequences.

Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for detecting errors in a client device and its associated applications while preserving the privacy of the user of the device. Methods can include obtaining and blinding contextual application data for an application on a device. Data regarding the application's digital certificate and device trustworthiness data are obtained and provided to a trust assessment server along with the blinded data. This server can provide indications that the device is trustworthy and the application is authentic, and can digitally sign the blinded data. The digital signature can be validated and the unblinded contextual application data can be obtained. If the unblinded data matches the contextual application data, the application can provide the digital signature, the indications, and the unblinded contextual application data to an error detection server, which in turn can indicate the application does not have errors.

Abstract: The invention features sublingual formulations of apomorphine and apomorphine prodrugs, and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders therewith.

Abstract: The application discloses pharmaceutical compounds of formula I useful for treating CNS diseases wherein m, s, R1 R5, R6 and R7 are as defined herein.

Abstract: A system for separating cut food products includes a flow inlet, a flow outlet, and at least one drum connecting the flow inlet and the flow outlet. The flow inlet may be oriented to direct the cut food product tangentially into the at least one drum. The flow inlet may be oriented to direct the cut food product into the at least one drum at a right angle to a longitudinal axis of the at least one drum. The at least one drum may be a plurality of drums including a first drum having the flow inlet and a second drum having the flow outlet. The system may include a passageway providing fluid communication from the first drum to the second drum. The passageway may include a tapered section. The flow inlet may be aligned with the flow outlet.

Abstract: Disclosed herein are novel compositions and methods for controlling the release of bile acid sequestrant to the stomach in order to treat or prevent upper GI tract disorders or disorders of the throat. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising at least one bile acid sequestrant dispersed in a polymeric matrix. The bile acid sequestrant composition may be administered alone or in combination with at least one proton pump inhibitor, and optionally one or more agents chosen from antacids, histamine H2-receptor antagonists, y-aminobutyric acid-I3 (GABA-B) agonists, prodrugs of GABA-B agonists, acid pump antagonists, protease inhibitors and GC-C agonists.